News & Media / Opinions & Features

Three Takeaways From The CVS-Aetna Merger

December 4, 2017

In a joint press release Sunday night, CVS Health and Aetna stated that one of the goals behind the nation’s largest pharmacy chain acquiring one of its largest health insurers is to save the healthcare system money.

Continue Reading

Amazon Is About To Disrupt The Drug Industry, But Not The Way Most Think

October 20, 2017

It’s now a foregone conclusion that Amazon.com, Inc. will enter the healthcare sector.

Continue Reading

Gilead-Kite: A New Transformative Deal For Biotech

August 30, 2017

After years of anticipation, the world learned on Monday that Gilead Sciences Inc. will acquire Kite Pharma Inc. for almost $12 billion in cash.

Continue Reading

How Martin Shkreli Used Social Media To Fuel His Short-Selling Shenanigans

July 20, 2017

Over the last several months, someone using the pseudonym “Art Doyle” released online reports — I use the word “reports” loosely — to attack several biotech stocks.

Continue Reading

Why The Street Should Fear The Senate Healthcare Bill

June 22, 2017

As the Republican Senate majority unveiled its draft healthcare bill Thursday, there was a rally in healthcare stocks in anticipation of reduced government regulation.

Continue Reading

Why Healthcare Reform Won’t Be Rushed — And It Isn’t Political

April 1, 2017

Republicans learned that they must tread carefully in their plans to replace the ACA as the consequences of their actions will result in significant disruption across the healthcare industry.

Continue Reading

Trump, Interest Rates, And Biotech Investing In 2017

December 23, 2016

We are heading into 2017 with a great deal of uncertainty, but if President-elect Trump governs the nation as he said he would – unconventionally and unpredictably – we may experience a significant uptick in market volatility as foreign governments and global markets react to America’s new stance in the world.

Continue Reading

Siemens And Northwell Announce Alliance, Enter Big Data Arms Race

December 1, 2016

In an era where a doctor’s office can generate a terabyte of data easily and toasters can speak to refrigerators, we are in an unprecedented age of information and connectivity.

Continue Reading

After Lilly Bombs, Could Alzheimer’s Become Healthcare’s Trumpshot?

November 30, 2016

If the healthcare industry’s approach to Alzheimer’s disease were a building project, it could best be described as constructing a skyscraper from the top down–possible, yet at best impractical.

Continue Reading

5 Healthcare Questions That Should (But Won’t) Be Asked At The Debate

October 7, 2016

As the election draws closer, issue polls consistently rank health care affordability at or near the top of American voters’ concerns.

Continue Reading